Latest Commercial Production News

Cauldron Energy has terminated its purchase agreement for river sand leases at Carnarvon and Derby, retaining the Onslow tenements with no further payments required, including cancellation of 2 million shares.

Latrobe Magnesium has commenced start-up operations at its Hazelwood North Demonstration Plant following EPA licence renewal, overcoming recent weather-related supply setbacks. The company aims to begin magnesium oxide production within the week as it advances toward full commissioning.

First Graphene Limited reveals significant progress in commercialising its PureGRAPH graphene technology, highlighting expanding global partnerships and a robust sales pipeline valued over A$10 million.

Horseshoe Metals has launched a new phase of reverse circulation drilling at its Horseshoe Lights Copper-Gold Project in Western Australia, targeting near-surface copper oxide and gold zones. Concurrently, the company is progressing offtake negotiations with major commodity traders.

Tamboran Resources has secured a pioneering approval from the Northern Territory Government to sell appraisal gas from its Beetaloo Basin exploration permits, marking a significant step toward local energy supply and revenue generation.

Brazilian Critical Minerals has reported exceptional in-situ recovery results at its Ema project, achieving rare earth leaching grades over 14 times higher than the natural mineralised levels. These breakthrough findings mark a significant step towards commercial production.

Genmin Limited has increased insider loans by A$0.5 million, reinforcing funding for its flagship Baniaka iron ore project in Gabon as it targets production in late 2026.

Papyrus Australia has marked significant progress in July 2025 with successful testing at its Rapid Prototyping facility and advancing plans for a commercial production site, while also writing down key investments.

Papyrus Australia Ltd reported a sharp increase in losses for FY2025, driven by impairment of its Egyptian investments, while securing new funding and advancing commercialization of its banana fibre technology.

EMVision Medical Devices reported a sharp increase in FY25 losses alongside a 51% revenue drop, yet marked significant progress in clinical trials for its innovative brain scanners and secured $8 million in government grants to fuel commercialisation.

Lynas Rare Earths reported a 20% revenue increase in FY25 driven by higher NdPr sales, yet net profit fell sharply amid ramp-up costs and market challenges. The company completed key growth projects and unveiled its Towards 2030 strategy focused on downstream expansion.

Mineral Resources Limited posted a $896 million statutory loss for FY25, driven by significant impairments, while Onslow Iron achieved commercial production and governance reforms reshape the board.